Nurse Practitioner · Tulsa, OK
NPI
1255564589
Since 2009
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1265 S Utica Ave, Suite 300
Tulsa, OK, 74104
Phone (918) 592-0999
Groups this clinician bills Medicare through
Medicare paid, 2024
$92K
3,477 services
Medicare patients, 2024
322
Average age 72
Drug cost, 2024
$6.8M
6,763 prescriptions
Company payments, 2025
$2,651
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Huong N Huynh was code J0897 (injection, denosumab, 1 mg), 2,640 times for 35 patients. In total Huong N Huynh billed 3,477 services in 11 codes, and Medicare paid $92K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-11-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,640 | 35 | $20.26 | $53K |
| 99214 Office E&M - Established | Office | 408 | 235 | $67.86 | $28K |
| 95251 Test - Miscellaneous | Office | 175 | 100 | $20.48 | $3,585 |
| 99213 Office E&M - Established | Office | 96 | 85 | $47.89 | $4,597 |
| 83036 Blood Count | Office | 50 | 43 | $9.52 | $476 |
| 96372 Injection Administration | Office | 46 | 37 | $8.95 | $412 |
| 76536 Ultrasound - Nonspecific | Office | 24 | 24 | $53.82 | $1,292 |
| 36415 Venipuncture Blood Collection | Office | 19 | 15 | $6.86 | $130 |
| 99442 Telephone Services | Office | 11 | 11 | $23.11 | $254 |
By year: 2022 $40K for 1,449 services; 2023 $81K for 3,421 services; 2024 $92K for 3,477 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 50 | 43 | $9.52 | $476 |
| 36415 Venipuncture Blood Collection | 19 | 15 | $6.86 | $130 |
Medicare prescription drug claims, 2024
In 2024, the drug Huong N Huynh prescribed most often to Medicare patients was Ozempic (Semaglutide), with 634 prescriptions and refills. In total Huong N Huynh wrote 6,763 Medicare prescriptions that cost $6.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 634 | 882 | 146 | $838K |
| Levothyroxine Sodium Generic | 454 | 1,212 | 149 | $3,771 |
| Mounjaro Tirzepatide | 347 | 413 | 76 | $437K |
| Jardiance Empagliflozin | 317 | 642 | 89 | $363K |
| Metformin Hcl Er Metformin Hcl | 258 | 669 | 79 | $2,905 |
| Atorvastatin Calcium Generic | 218 | 576 | 69 | $3,222 |
| Pioglitazone Hcl Generic | 199 | 515 | 58 | $2,415 |
| Trulicity Dulaglutide | 171 | 254 | 49 | $246K |
| Tresiba Flextouch U-200 Insulin Degludec | 165 | 347 | 59 | $275K |
| Rosuvastatin Calcium Generic | 155 | 417 | 60 | $2,141 |
| Metformin Hcl Generic | 143 | 364 | 45 | $1,511 |
| Synthroid Levothyroxine Sodium | 140 | 327 | 41 | $13K |
| Farxiga Dapagliflozin Propanediol | 118 | 257 | 31 | $136K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 104 | 224 | 49 | $19K |
| Glimepiride Generic | 94 | 225 | 31 | $592 |
Brand drugs: 3,705 claims; generic drugs: 2,759 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Huong N Huynh $2,651 ($2,651 in general payments such as food, travel and fees) from 24 companies. The largest payer was Medtronic, Inc. with $265.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 2 | $265 |
| Abbott Laboratories ABT | 16 | $254 |
| Lilly USA, LLC LLY | 10 | $228 |
| Tandem Diabetes Care, Inc. TNDM | 6 | $228 |
| Amgen Inc. AMGN | 16 | $219 |
| Novo Nordisk Inc NVO | 13 | $194 |
| Dexcom, Inc. DXCM | 11 | $194 |
| Amneal Pharmaceuticals LLC AMRX | 8 | $175 |
| Insulet Corporation PODD | 2 | $134 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $130 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.